Condition: Tricuspid Regurgitation · Sponsor: Shanghai Huihe Medical Technology Co., Ltd
Evaluate the effectiveness and safety of the transcatheter tricuspid annuloplasty system manufactured by Shanghai Huihe Medical Technology Co., Ltd. for the treatment of patients with moderate-severe or worse tricuspid regurgitation
This description comes directly from the study's public registry record.
Sally Yan, project supervisor · 18800263183 · Sally.yan@hh-healthcare.com
Always discuss trial participation with your own doctor first.
| Shanghai Huihe Healthcare Tecnology Co.,Ltd. | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05434507